Immunocore Holdings (IMCR) Debt to Equity (2019 - 2025)
Immunocore Holdings (IMCR) has disclosed Debt to Equity for 7 consecutive years, with $1.03 as the latest value for Q4 2025.
- Quarterly Debt to Equity fell 4.82% to $1.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.03 through Dec 2025, down 4.82% year-over-year, with the annual reading at $1.03 for FY2025, 4.82% down from the prior year.
- Debt to Equity hit $1.03 in Q4 2025 for Immunocore Holdings, up from $0.99 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.22 in Q2 2024 to a low of $0.13 in Q4 2023.
- Historically, Debt to Equity has averaged $0.83 across 5 years, with a median of $1.03 in 2025.
- Biggest five-year swings in Debt to Equity: crashed 67.23% in 2021 and later skyrocketed 732.77% in 2024.
- Year by year, Debt to Equity stood at $0.22 in 2021, then plummeted by 34.7% to $0.14 in 2022, then fell by 8.14% to $0.13 in 2023, then surged by 732.77% to $1.08 in 2024, then dropped by 4.82% to $1.03 in 2025.
- Business Quant data shows Debt to Equity for IMCR at $1.03 in Q4 2025, $0.99 in Q3 2025, and $1.01 in Q2 2025.